• Profile
Close
Jj 4 1534570352
Dr. Jyotsna Joshi
is a specialist in Pulmonology and Sleep Medicine

Dr. Jyotsna Joshi is a specialist in pulmonology and sleep medicine. She has held various key positions in esteemed organisations with more than 150 articles in National and International journals.

This Sunday, we revisit an old article fro... more»This Sunday, we revisit an old article from our archives. Dr. Jyotsna Joshi discusses the diagnosis and pharmacotherapy for Obesity Hypoventilation Syndrome (OHS), which once prevalent in high-income countries, is slowly on the rise in low- and middle-income countries too. «less
Aug 30, 2020
Test your knowledge on pulmonary disease a... more»Test your knowledge on pulmonary disease and the GINA guidelines. Dr. Jyotsna Joshi quizzes you on ABPA diagnostic criteria, cystic fibrosis mutations, ATS indications for sarcoidosis, signs in CXR, and stepwise treatment for asthma as per GINA guidelines. «less
Jul 23, 2020
Dr. Jyotsna Joshi writes on management of ... more»Dr. Jyotsna Joshi writes on management of asthma during pregnancy, labour, and postpartum, including recommendations on evaluation, treatment, and step therapy for asthma control in pregnant women. «less
Oct 01, 2019
Dr. Jyotsna Joshi discusses diagnosis and ... more»Dr. Jyotsna Joshi discusses diagnosis and treatment of Interstitial Lung Diseases (ILD), an umbrella term for a group of disorders and how despite there being significant improvement in knowledge of pathogenesis, the aetiology still remains unknown for many cases. «less
Sep 06, 2019
Dr. Jyotsna Joshi explains the classificat... more»Dr. Jyotsna Joshi explains the classification and goals and steps in management of bronchial asthma based on the GINA guidelines; variable dose therapy, immunotherapy, and monitoring of treatment in patients. «less
Mar 25, 2019
Prof. Dr. Jyotsna Joshi asserts the import... more»Prof. Dr. Jyotsna Joshi asserts the importance of preventive adult vaccinations, particularly pneumococcal and influenza vaccination and also throws light on the schedule for dual vaccination. «less
Feb 06, 2019
Up to 50% cases of AE COPD are due to bact... more»Up to 50% cases of AE COPD are due to bacterial infections; therefore, antibiotic use should be selective says Dr. Joshi as she expertly summarises the recent NICE update for initiating antibiotics in COPD; acute exacerbation being a common occurrence in the natural course of COPD. «less
Jan 16, 2019
Dr. Jyotsna Joshi, a noted Pulmonologist d... more»Dr. Jyotsna Joshi, a noted Pulmonologist discusses a case where persisting pleural pain in a patient was misdiagnosed as TB when it was actually pseudomesotheliomatous adenocarcinoma. «less
Dec 12, 2018
On World COPD Day 2018, Dr. Jyotsna Joshi,... more»On World COPD Day 2018, Dr. Jyotsna Joshi, a renowned Pulmonologist discusses the pathogenesis and treatment guidance for the disease. «less
Nov 21, 2018
Dr. Jyotsna Joshi, a noted pulmonologist p... more»Dr. Jyotsna Joshi, a noted pulmonologist provides a comprehensive clinical management protocol for handling acute bronchial asthma flare-ups that are commonly reported as a result of air pollution caused during Diwali. «less
Nov 07, 2018
Dr. Jyotsna Joshi, a noted Pulmonologist d... more»Dr. Jyotsna Joshi, a noted Pulmonologist discusses the clinical presentation, diagnostic criteria, and treatment modality for Obliterative Bronchiolitis (OB), also commonly known as Popcorn Lung. «less
Oct 16, 2018
Dr. Jyotsna Joshi, a noted Pulmonologist t... more»Dr. Jyotsna Joshi, a noted Pulmonologist takes us through the classification and drug management protocol of drug-resistant Tuberculosis. «less
Oct 02, 2018
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay